What's Happening?
Researchers at UC Berkeley, led by doctoral student Sonali Mali and Professor Diana Bautista, have discovered that specific SARS-CoV-2 viral proteins directly stimulate sensory nerves, causing symptoms like sneezing, coughing, and pain. Published in the
journal Neuron on November 13, 2026, the study identifies the papain-like protease (PLpro) as a key protein responsible for activating nociceptors, which are sensory nerves found in the airways. This direct activation mechanism differs from the previously understood pathway where symptoms were thought to arise solely from inflammatory mediators released by infected cells. The research indicates that PLpro interacts with the TRPA1 ion channel on sensory neurons, the same channel activated by irritants like wasabi and garlic, leading to the release of neuropeptides that trigger physiological responses. The team demonstrated that purified PLpro alone could activate cultured sensory neurons and induce frequent sneezing in mice, suggesting a direct link between the viral protein and symptom manifestation.
Why It's Important?
This discovery is significant because it provides the first evidence that viral proteins can directly activate sensory nerves to induce symptoms, offering a new understanding of how viruses cause illness. This direct activation mechanism could explain some chronic conditions associated with long COVID, such as persistent cough, headache, and shortness of breath. From a therapeutic perspective, the findings suggest that targeting viral proteases like PLpro could be a viable strategy not only to inhibit viral replication but also to alleviate symptoms. While existing drugs like Paxlovid target another protease (Mpro), the potential to target PLpro opens new avenues for drug development. Inhibiting PLpro could help manage symptoms like coughing, which might reduce viral spread and potentially prevent severe COVID-19 outcomes, especially in vulnerable individuals. This research broadens the understanding of virus-host interactions beyond immune responses, highlighting the direct role of the nervous system in viral pathogenesis.
What's Next?
The UC Berkeley team plans to further investigate the roles of other viral proteins and how different viruses trigger symptoms. They have already found that Mpro also directly stimulates sensory neurons, albeit with different reactions than PLpro, and that influenza viruses employ distinct mechanisms. Future research will explore what happens when neurons themselves become infected and how they contribute to the antiviral response. The findings also prompt a re-evaluation of existing protease inhibitors that were developed but not approved for COVID-19, suggesting they might have utility in symptom management. The researchers aim to understand whether symptoms like coughing and sneezing primarily benefit the host by expelling the virus or aid the virus in spreading to new hosts. This ongoing work could lead to the development of novel therapeutic interventions that specifically target the neural pathways involved in viral symptom generation.
Beyond the Headlines
This research delves into a fundamental biological question about how pathogens interact with the nervous system, an area previously underexplored. The finding that viral proteins can directly hijack sensory pathways challenges the conventional view that symptoms are solely a byproduct of the immune response. This deeper understanding could have implications beyond COVID-19, potentially revealing common mechanisms by which various viral and bacterial infections induce symptoms. Ethically, this knowledge could lead to more targeted treatments that reduce suffering without broadly suppressing the immune system. Legally, it might influence regulatory pathways for drug development, encouraging the repurposing of existing compounds or the creation of new ones focused on symptom relief via neural modulation. Culturally, a clearer understanding of symptom origins could help demystify long COVID and other post-viral syndromes, fostering greater empathy and more effective management strategies for affected individuals.
